Martek Biosciences Report issue

For profit Phase 1
Founded: Columbia MD United States (1985)
Status: Acquired by DSM (2011) → now Thermo Fisher Scientific (2017)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 1 Trials (2)

Key: Martek Biosciences (0) Acquired (2)

lactobacillus rhamnosus (1 trial)

live attenuated influenza virus vaccine (Flumist) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 2